Skip to main content
. 2022 May 6;8(18):eabj1624. doi: 10.1126/sciadv.abj1624

Table 3. Summary of CancerVar prediction of CIViC mutations.

CIViC Model-based CancerVar (OPAI) Rule-based CancerVar
Oncogenic Neutral I (Strong) II (Potential) III (VUS) IV (Benign)
A: Validated 17 2 2 7 0 10
B: Clinical 259 40 111 109 61 18
C: Case study 792 30 178 439 198 7
D: Preclinical 466 22 91 277 119 1
E: Inferential 47 6 5 11 33 4
Total 1581 100 387 843 411 40